American Chemical Society Resolves to Recognize the Career Contributions of Magid Abou-Gharbia, PhD, FRSC, Laura H. Carnell Professor of Medicinal Chemistry

RESOLUTION

Dr. Magid Abou-Gharbia

BE IT RESOLVED that the Board of Directors of the American Chemical Society recognizes Dr. Magid Abou-Gharbia, Laura H. Carnell Professor at Temple University School of Pharmacy, on the occasion of his stepping down from his position as founding Director of the Moulder Center for Drug Discovery at Temple University School of Pharmacy (2008-2020), and for his continuing service to the Society as a member for 47 years.

The Board especially recognizes Dr. Abou-Gharbia’s significant contributions to the establishment of the Heroes of Chemistry Award in 1996, which recognizes teams responsible for the development of innovative, impactful products based on chemistry. He continues to champion Heroes of Chemistry and has been a contributor to this program as a judge for many years.

As a member of the Board Standing Committee on Corporation Associates for 25 years, Dr. Abou-Gharbia made contributions toward establishing key ACS initiatives of interest to the pharmaceutical and chemical industries. He played a major role in establishing the annual Pharma Leaders Meeting, which provides a forum for the discussion of common challenges and the outreach of ACS with pharmaceutical companies, and hosted the inaugural meeting in 2003 at Wyeth Pharmaceuticals, Collegeville, Pennsylvania.

During his tenure at Wyeth Pharmaceuticals (1982-2009) Dr. Abou-Gharbia actively encouraged his colleagues to contribute to and participate in American Chemical Society activities. He supported the ACS Scholarship programs by sponsoring three scholarships: two pre-doctoral fellowships (ACS Scholars) and one Project SEED program and was a strong supporter of the Division of Medicinal Chemistry in the form of session, meeting and graduate fellowship sponsorship. He suggested and established joint Scientific Symposia between ACS Division of Medicinal Chemistry and the European Federation of Medicinal Chemistry.

The Board extends congratulations to Dr. Abou-Gharbia, and offers best wishes for his continuing professional endeavors.